Back

Safety and efficacy of potassium binders on hyperkalemia: a novel systematic review and meta-analysis of randomized controlled trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heart failure pharmacotherapy updates Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Maite Werlang

Rio Do Sul (Brazil)

3 More presentations in this session

Presentation thumbnail
Gender differences in mortality benefit of raas inhibitors in heart failure: a retrospective cohort study
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
6 years of ARNI use in Israel - effectiveness analysis in real world data
Professor Z. Iakobishvili (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Impact of sodium-glucose co-transporter 2 inhibition on right ventricular function and pulmonary artery systolic pressure across heart failure phenotypes: a meta-analytic approach
Doctor M. Patricio (Manila, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Patiromer use for the treatment of hyperkaliemia in patients with heart failure and chronic kidney disease, real-world experience
thumbnail
Congress Presentation
Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry
thumbnail
Congress Presentation
Optimising heart failure therapy: potassium binders and the initiation and titration of mineralocorticoid receptor antagonists

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources